Tfb Advisors LLC United Therapeutics Corp Transaction History

Tfb Advisors LLC

$373 Million
Q2 2025

A detailed history of Tfb Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Tfb Advisors LLC holds 4,021 shares of UTHR stock, worth $1.21 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,021

Previous 3,046 32.01%

Holding current value

$1.21 Million

Previous $938,000 23.13%

% of portfolio

0.31%

Previous 0.28%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$276.47 - $328.4 $269,558 - $320,190	975 Added 32.01%	4,021 $1.16 Million
Q1 2025 May 14, 2025	BUY	$304.42 - $380.78 $238,665 - $298,531	784 Added 34.66%	3,046 $938,000
Q4 2024 Jan 29, 2025	SELL	$348.66 - $410.0 $10,111 - $11,890	-29 Reduced 1.27%	2,262 $798,000
Q3 2024 Oct 31, 2024	BUY	$311.04 - $363.55 $116,951 - $136,694	376 Added 19.63%	2,291 $820,000
Q2 2024 Jul 30, 2024	BUY	$228.26 - $319.04 $1,369 - $1,914	6 Added 0.31%	1,915 $610,000
Q1 2024 May 03, 2024	BUY	$210.76 - $249.51 $188,840 - $223,560	896 Added 88.45%	1,909 $438,000
Q4 2023 Jan 18, 2024	SELL	$214.88 - $256.94 $183,077 - $218,912	-852 Reduced 45.68%	1,013 $222,000
Q3 2023 Nov 13, 2023	SELL	$211.82 - $248.24 $18,851 - $22,093	-89 Reduced 4.55%	1,865 $421,000
Q2 2023 Jul 18, 2023	BUY	$205.19 - $232.99 $88,436 - $100,418	431 Added 28.3%	1,954 $431,000
Q1 2023 Apr 10, 2023	BUY	$212.99 - $276.17 $56,016 - $72,632	263 Added 20.87%	1,523 $341,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $259,497 - $353,341	1,260 New	1,260 $350,000

Others Institutions Holding UTHR

# of Institutions

730

Shares Held

43.3M

Call Options Held

125K

Put Options Held

124K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.

Account